Cargando…

Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes

PURPOSE: To explore the relevance of cytogenetic or molecular genetic abnormalities to clinical variables, including clinical and laboratory characteristics and prognosis in Chinese patients with myelodysplastic syndromes (MDS). METHODS: A total of 634 consecutive patients diagnosed with MDS at The...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Xuefen, Wang, Lu, Jiang, Lingxu, Luo, Yingwan, Lin, Peipei, Yang, Wenli, Ren, Yanling, Ma, Liya, Zhou, Xinping, Mei, Chen, Ye, Li, Xu, Gaixiang, Xu, Weilai, Yang, Haiyang, Lu, Chenxi, Jin, Jie, Tong, Hongyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940222/
https://www.ncbi.nlm.nih.gov/pubmed/33609081
http://dx.doi.org/10.1002/cam4.3786
_version_ 1783661906432622592
author Yan, Xuefen
Wang, Lu
Jiang, Lingxu
Luo, Yingwan
Lin, Peipei
Yang, Wenli
Ren, Yanling
Ma, Liya
Zhou, Xinping
Mei, Chen
Ye, Li
Xu, Gaixiang
Xu, Weilai
Yang, Haiyang
Lu, Chenxi
Jin, Jie
Tong, Hongyan
author_facet Yan, Xuefen
Wang, Lu
Jiang, Lingxu
Luo, Yingwan
Lin, Peipei
Yang, Wenli
Ren, Yanling
Ma, Liya
Zhou, Xinping
Mei, Chen
Ye, Li
Xu, Gaixiang
Xu, Weilai
Yang, Haiyang
Lu, Chenxi
Jin, Jie
Tong, Hongyan
author_sort Yan, Xuefen
collection PubMed
description PURPOSE: To explore the relevance of cytogenetic or molecular genetic abnormalities to clinical variables, including clinical and laboratory characteristics and prognosis in Chinese patients with myelodysplastic syndromes (MDS). METHODS: A total of 634 consecutive patients diagnosed with MDS at The First Affiliated Hospital, Zhejiang University School of Medicine from June 2008 to May 2018 were retrospectively included in this study. All patients had evaluable cytogenetic analysis, and 425 patients had MDS‐related mutations sequencing. RESULTS: 38.6% of patients displayed abnormal karyotypes. The most common cytogenetic abnormality was +8 (31%). Sole +8 was related to female (p = 0.002), hemoglobin >10 g/dL (p = 0.03), and <60 years old (p = 0.046). TP53 mutations were associated with complex karyotype (CK) (p < 0.001). DNMT3A mutations correlated with ‐Y (p = 0.01) whereas NRAS mutations correlated with 20q‐ (p = 0.04). The overall survival (OS) was significantly inferior in patients with +8 compared with those with normal karyotype (NK) (p = 0.003). However, the OS of sole +8 and +8 with one additional karyotypic abnormality was not different from NK (p = 0.16), but +8 with two or more abnormalities had a significantly shorter OS than +8 and +8 with one additional karyotypic abnormality (p = 0.02). In multivariable analysis, ≥60 years old, marrow blasts ≥5% and TP53 mutations were independent predictors for poor OS (p < 0.05), whereas SF3B1 mutations indicated better prognosis. Male IDH1 and IDH2 mutations and marrow blasts ≥5% were independent risk factors for worse leukemia free survival (LFS) (p < 0.05). CONCLUSION: In this population of Chinese patients, trisomy 8 is the most common karyotypic abnormality. Patients with +8 showed a poorer OS compared with patients with NK. Sole +8 and +8 with one additional karyotypic abnormality had similar OS with NK, whereas +8 with two or more abnormalities had a significantly shorter OS. DNMT3A mutations correlated with ‐Y and NRAS mutations correlated with 20q‐. TP53 mutations were associated with CK and had a poor OS. SF3B1 mutations indicated a favorable OS. IDH1 and IDH2 mutations independently indicated inferior LFS.
format Online
Article
Text
id pubmed-7940222
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-79402222021-03-16 Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes Yan, Xuefen Wang, Lu Jiang, Lingxu Luo, Yingwan Lin, Peipei Yang, Wenli Ren, Yanling Ma, Liya Zhou, Xinping Mei, Chen Ye, Li Xu, Gaixiang Xu, Weilai Yang, Haiyang Lu, Chenxi Jin, Jie Tong, Hongyan Cancer Med Clinical Cancer Research PURPOSE: To explore the relevance of cytogenetic or molecular genetic abnormalities to clinical variables, including clinical and laboratory characteristics and prognosis in Chinese patients with myelodysplastic syndromes (MDS). METHODS: A total of 634 consecutive patients diagnosed with MDS at The First Affiliated Hospital, Zhejiang University School of Medicine from June 2008 to May 2018 were retrospectively included in this study. All patients had evaluable cytogenetic analysis, and 425 patients had MDS‐related mutations sequencing. RESULTS: 38.6% of patients displayed abnormal karyotypes. The most common cytogenetic abnormality was +8 (31%). Sole +8 was related to female (p = 0.002), hemoglobin >10 g/dL (p = 0.03), and <60 years old (p = 0.046). TP53 mutations were associated with complex karyotype (CK) (p < 0.001). DNMT3A mutations correlated with ‐Y (p = 0.01) whereas NRAS mutations correlated with 20q‐ (p = 0.04). The overall survival (OS) was significantly inferior in patients with +8 compared with those with normal karyotype (NK) (p = 0.003). However, the OS of sole +8 and +8 with one additional karyotypic abnormality was not different from NK (p = 0.16), but +8 with two or more abnormalities had a significantly shorter OS than +8 and +8 with one additional karyotypic abnormality (p = 0.02). In multivariable analysis, ≥60 years old, marrow blasts ≥5% and TP53 mutations were independent predictors for poor OS (p < 0.05), whereas SF3B1 mutations indicated better prognosis. Male IDH1 and IDH2 mutations and marrow blasts ≥5% were independent risk factors for worse leukemia free survival (LFS) (p < 0.05). CONCLUSION: In this population of Chinese patients, trisomy 8 is the most common karyotypic abnormality. Patients with +8 showed a poorer OS compared with patients with NK. Sole +8 and +8 with one additional karyotypic abnormality had similar OS with NK, whereas +8 with two or more abnormalities had a significantly shorter OS. DNMT3A mutations correlated with ‐Y and NRAS mutations correlated with 20q‐. TP53 mutations were associated with CK and had a poor OS. SF3B1 mutations indicated a favorable OS. IDH1 and IDH2 mutations independently indicated inferior LFS. John Wiley and Sons Inc. 2021-02-20 /pmc/articles/PMC7940222/ /pubmed/33609081 http://dx.doi.org/10.1002/cam4.3786 Text en © 2021 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Cancer Research
Yan, Xuefen
Wang, Lu
Jiang, Lingxu
Luo, Yingwan
Lin, Peipei
Yang, Wenli
Ren, Yanling
Ma, Liya
Zhou, Xinping
Mei, Chen
Ye, Li
Xu, Gaixiang
Xu, Weilai
Yang, Haiyang
Lu, Chenxi
Jin, Jie
Tong, Hongyan
Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes
title Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes
title_full Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes
title_fullStr Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes
title_full_unstemmed Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes
title_short Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes
title_sort clinical significance of cytogenetic and molecular genetic abnormalities in 634 chinese patients with myelodysplastic syndromes
topic Clinical Cancer Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940222/
https://www.ncbi.nlm.nih.gov/pubmed/33609081
http://dx.doi.org/10.1002/cam4.3786
work_keys_str_mv AT yanxuefen clinicalsignificanceofcytogeneticandmoleculargeneticabnormalitiesin634chinesepatientswithmyelodysplasticsyndromes
AT wanglu clinicalsignificanceofcytogeneticandmoleculargeneticabnormalitiesin634chinesepatientswithmyelodysplasticsyndromes
AT jianglingxu clinicalsignificanceofcytogeneticandmoleculargeneticabnormalitiesin634chinesepatientswithmyelodysplasticsyndromes
AT luoyingwan clinicalsignificanceofcytogeneticandmoleculargeneticabnormalitiesin634chinesepatientswithmyelodysplasticsyndromes
AT linpeipei clinicalsignificanceofcytogeneticandmoleculargeneticabnormalitiesin634chinesepatientswithmyelodysplasticsyndromes
AT yangwenli clinicalsignificanceofcytogeneticandmoleculargeneticabnormalitiesin634chinesepatientswithmyelodysplasticsyndromes
AT renyanling clinicalsignificanceofcytogeneticandmoleculargeneticabnormalitiesin634chinesepatientswithmyelodysplasticsyndromes
AT maliya clinicalsignificanceofcytogeneticandmoleculargeneticabnormalitiesin634chinesepatientswithmyelodysplasticsyndromes
AT zhouxinping clinicalsignificanceofcytogeneticandmoleculargeneticabnormalitiesin634chinesepatientswithmyelodysplasticsyndromes
AT meichen clinicalsignificanceofcytogeneticandmoleculargeneticabnormalitiesin634chinesepatientswithmyelodysplasticsyndromes
AT yeli clinicalsignificanceofcytogeneticandmoleculargeneticabnormalitiesin634chinesepatientswithmyelodysplasticsyndromes
AT xugaixiang clinicalsignificanceofcytogeneticandmoleculargeneticabnormalitiesin634chinesepatientswithmyelodysplasticsyndromes
AT xuweilai clinicalsignificanceofcytogeneticandmoleculargeneticabnormalitiesin634chinesepatientswithmyelodysplasticsyndromes
AT yanghaiyang clinicalsignificanceofcytogeneticandmoleculargeneticabnormalitiesin634chinesepatientswithmyelodysplasticsyndromes
AT luchenxi clinicalsignificanceofcytogeneticandmoleculargeneticabnormalitiesin634chinesepatientswithmyelodysplasticsyndromes
AT jinjie clinicalsignificanceofcytogeneticandmoleculargeneticabnormalitiesin634chinesepatientswithmyelodysplasticsyndromes
AT tonghongyan clinicalsignificanceofcytogeneticandmoleculargeneticabnormalitiesin634chinesepatientswithmyelodysplasticsyndromes